RESUMEN
A novel κ-carrageenase gene (CgkB) has been cloned from Pedobacter hainanensis NJ-02 and expressed heterologously in Escherichia coli BL21 (DE3). It consisted of 1935 bp and encoded 644 amino acid residues with a molecular weight of 71·61 kDa. The recombinant enzyme showed maximal activity of 2458 U mg-1 at 40°C and pH 8·0. Additionally, it could retain more than 70% of its maximal activity after being incubated at pH of 5·5-10·0 below 40°C. K+ and a broad range of NaCl can activate the enzyme. The Km and Vmax of CgkB was 2·4 mg ml-1 and 126 mmol mg-1 min-1 . The ESI-MS analysis of hydrolysates indicated that the enzyme can endolytically depolymerize the carrageenan into tetrasaccharides and hexasaccharides. The results indicated that the enzyme with high activity could be a valuable enzyme tool to produce carrageenan oligosaccharides with various activities. SIGNIFICANCE AND IMPACT OF THE STUDY: Enzymatic preparation of carrageenan oligosaccharides has drawn increased attention due to their various physiological activities. It is urgent to explore enzyme tools with higher activity and better stability. In this work, a novel κ-carrageenase was identified and characterized from marine bacterium Pedobacter hainanensis NJ-02. The enzyme with high activity could be a valuable tool to produce carrageenan oligosaccharides with various activities.
Asunto(s)
Proteínas Bacterianas/genética , Clonación Molecular/métodos , Glicósido Hidrolasas/genética , Pedobacter/enzimología , Pedobacter/genética , Secuencia de Aminoácidos , Secuencia de Bases , Carragenina/metabolismo , ADN Bacteriano/genética , Escherichia coli/genética , Escherichia coli/metabolismo , Glicósido Hidrolasas/metabolismo , Concentración de Iones de Hidrógeno , Oligosacáridos/metabolismo , Pedobacter/metabolismo , Alineación de Secuencia , Análisis de Secuencia de ADNRESUMEN
BACKGROUND: Transoral rigid laryngoscopy with videostroboscopy is the most practical method to visualise the vocal folds. The optimal topical anaesthesia regimen for transoral rigid laryngoscopy has not yet been established. OBJECTIVE: To compare patient comfort and compliance with various topical anaesthetics for transoral rigid laryngoscopy. METHODS: Each of 10 patients received a random topical administration of either 2 per cent lidocaine gel, 1 per cent tetracaine gel or 1 per cent tetracaine solution, 10 minutes before undergoing rigid laryngoscopy with videostroboscopy. During follow-up laryngoscopies, the agent with the lowest mean visual analogue scale score for discomfort was then used to study the timing of topical anaesthetic application: the agent was given to the patient 5, 10 or 15 minutes before laryngoscopy (with the timing randomly selected). RESULTS: Compared with lidocaine gel or tetracaine gel, laryngoscopy with topical tetracaine solution was more comfortable. There was a statistically significant difference in discomfort score between the 5 and 10 minute application groups, but not between the 10 and 15 minute groups. CONCLUSION: Tetracaine solution, applied topically 10 minutes before transoral rigid laryngoscopy, significantly decreases patient discomfort.
Asunto(s)
Anestesia Local/métodos , Enfermedades de la Laringe/cirugía , Laringoscopía/métodos , Dolor/tratamiento farmacológico , Tetracaína/administración & dosificación , Adulto , Estudios Cruzados , Femenino , Humanos , Enfermedades de la Laringe/tratamiento farmacológico , Lidocaína/administración & dosificación , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Estudios Prospectivos , Adulto JovenRESUMEN
Twenty-four patients with obstructed defecation due to rectal intussusception diagnosed by defecography were treated with rectopexy either by the Wells technique (9 patients) or by Orr's operation (15 patients). After follow-up from one to eight years, defecography demonstrated disappearance of the intussusception in 22 patients. None of the patients were completely relieved of their symptoms. Nine (41 percent; 95 percent confidence limits: 21-64) were improved and 13 were unchanged (59 percent; 95 percent confidence limits: 36-79), with no difference between the two procedures. One patient with solitary rectal ulcer was improved, and the ulcer disappeared. Four patients with moderate preoperative incontinence became continent postoperatively, but obstructed defecation was only improved in two of these patients. It is concluded that rectal intussusception is probably a secondary phenomenon in patients with obstructed defecation and that a conservative attitude toward surgery should be adopted.
Asunto(s)
Intususcepción/cirugía , Enfermedades del Recto/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Canal Anal/fisiopatología , Cirugía Colorrectal/métodos , Defecación , Femenino , Humanos , Obstrucción Intestinal/etiología , Intususcepción/complicaciones , Intususcepción/diagnóstico por imagen , Intususcepción/fisiopatología , Masculino , Persona de Mediana Edad , Radiografía , Enfermedades del Recto/complicaciones , Enfermedades del Recto/diagnóstico por imagen , Enfermedades del Recto/fisiopatologíaRESUMEN
PURPOSE: The somatostatin analog, octreotide, has previously been found to influence rectal sensation and may also influence anal resting pressure. METHODS: We studied the effect of octreotide on anal resting pressure and rectal compliance in eight healthy patients. Octreotide was administered intravenously as a bolus injection in doses of 100 and 10 micrograms or as infusion of 250 micrograms/hour on separate days and compared with placebo. RESULTS: Within one minute after a bolus injection of 100 micrograms of octreotide, anal resting pressure increased from 56 +/- 12 to 96 +/- 16 cm H2O (P < 0.005). Octrotide had no effect on rectal sensitivity or compliance measurements. Octreotide counteracted rectoanal reflex by increasing anal pressure almost to the level found with an empty rectum. CONCLUSION: Somatostatin thus seems to contribute to the regulation of rectoanal reflex.
Asunto(s)
Canal Anal/efectos de los fármacos , Defecación/efectos de los fármacos , Fármacos Gastrointestinales/farmacología , Octreótido/farmacología , Recto/efectos de los fármacos , Adulto , Canal Anal/inervación , Canal Anal/fisiología , Defecación/fisiología , Femenino , Homeostasis/efectos de los fármacos , Humanos , Infusiones Intravenosas , Inyecciones Intravenosas , Masculino , Manometría , Persona de Mediana Edad , Presión , Recto/inervación , Recto/fisiología , Reflejo/efectos de los fármacosRESUMEN
Sixty-nine patients presenting over a 10-year period with peritoneal carcinomatosis from appendiceal cancer were treated with cytoreductive surgery combined with intraperitoneal chemotherapy. The three-year survival is 89.5 percent in patients (38/69) with pseudomyxoma peritonei, 34.5 percent in patients (25/69) with cystadenocarcinoma, and 38.1 percent in patients (6/69) with adenocarcinoma (P < 0.01). In this study, a classification of residual disease following the cytoreductive surgery was used. The prognosis of the patients with minimal residual disease was better than that of those with moderate or gross disease, showing a 91.6 percent three-year survival compared with 47.8 percent and 20 percent, respectively (P < 0.01). The patients without lymphatic or hematogenous metastases had a better three-year survival than those with metastases (75.1 percent vs. 28.6 percent; P < 0.01). These findings suggest that peritoneal carcinomatosis from appendiceal cancer can be treated with long-term disease-free survival. The patients with low malignant potential cancer, complete cytoreduction, and no metastases showed the most effective disease control.